An inverse correlation between Skp2 expression and the expression of ER and PGR has been reported by others investigating breast cancer [59] and other studies suggest that Skp2B may modulate the activity of the estrogen receptor [60], [61]. Here, SKP2 is linked to breast carcinoma.